Uveitic Glaucoma Clinical Presentation

  • Author: Leon Herndon Jr, MD; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: May 15, 2012
 

History

Symptoms with acute iridocyclitis may include blurred vision, ocular pain, brow ache, and other ocular disturbances.

  • Blurred vision: It often is difficult to know if the blurred vision is due to glaucoma, uveitis, or complications associated with the uveitis.
  • Ocular pain: Pain is a frequent finding in acute iridocyclitis but often is not seen with subacute or chronic iridocyclitis. Some patients with markedly elevated IOP often have severe eye pain associated with corneal edema.
  • Brow ache: Ocular pain associated with elevated IOP often is referred to the brow on the affected side.
  • Ocular disturbances: Other ocular disturbances (eg, photophobia, colored halos) may be associated with acute iridocyclitis and corneal edema, respectively.
Next

Physical

  • The cornea may reveal band keratopathy, epithelial dendrites, or stromal scarring from herpetic infections. Corneal epithelial edema associated with acutely elevated IOP may give rise to a steamy appearance. Keratic precipitates may be present on the endothelium and have different characteristics that signify various diagnoses.
  • The hallmark of anterior uveitis is the presence of cells and flare in the anterior chamber. Cellular infiltration is due to release of chemotactic factors into the anterior chamber, and flare results from leakage of protein into the anterior chamber.
  • The iris should be examined for evidence of stromal atrophy, nodules, and posterior synechiae and PAS. Inflammation can result in engorgement of the blood vessels in both the iris stroma and the angle, which can be confused with rubeosis iridis.
  • The lens may have pigment on the anterior capsule, and posterior subcapsular opacification may be due to uveitis or to chronic corticosteroid therapy.
  • The vitreous cavity may show the presence of cells or snowball opacities.
  • The IOP may be low, normal, or high due to variations in aqueous secretion, amount of outflow obstruction, and dose of corticosteroids being used.
  • Gonioscopy should be performed to detect the presence of PAS and to assess the degree of angle closure.
  • The posterior segment should be examined, paying particular attention to the optic nerve to document morphologic changes consistent with glaucoma. Other possible posterior segment findings include cystoid macular edema, retinitis, perivascular sheathing, choroidal infiltrates, or retinal detachment.
Previous
Next

Causes

Many specific uveitic entities may lead to the development of glaucoma. Some of the more common syndromes are listed below.

  • Juvenile rheumatoid arthritis
    • Juvenile rheumatoid arthritis (JRA) is defined as an arthritis, with a duration of at least 3 months, that begins prior to age 16 years and is diagnosed after exclusion of other causes of arthritis.
    • Glaucoma is a common complication of chronic uveitis in patients with JRA and most frequently is caused by progressive closure of the angle by PAS.
    • Since the uveitis frequently is treated with prolonged topical corticosteroids, steroid-induced glaucoma may occur. The reported incidence of glaucoma varies from 14-22%.
  • Fuchs heterochromic iridocyclitis
    • Fuchs heterochromic iridocyclitis (FHI) usually is unilateral and appears between the third and fourth decades with the insidious onset of mild, chronic anterior uveitis that usually is asymptomatic.
    • The glaucoma associated with FHI resembles primary open-angle glaucoma.
    • Gonioscopic evaluation may reveal multiple fine blood vessels, arranged either radially or concentrically in the trabecular meshwork.
    • Cataract is a constant feature of FHI, whereas glaucoma has been reported to occur in 6-47% of cases.
    • Low-grade inflammation does not need treatment with anti-inflammatory or immunosuppressive agents.
  • Posner-Schlossman syndrome is characterized by a number of unusual features, including unilateral involvement, recurrent attacks of often very mild cyclitis, marked elevation of IOP, open angle, and occasional heterochromia. The condition typically affects individuals aged 20-50 years and resolves spontaneously regardless of treatment.
  • Herpetic uveitis
    • Herpes simplex
      • Ocular manifestations of herpes simplex virus have been classified in accordance with the site of the corneal involvement and the presence or absence of associated uveitis, including herpetic superficial keratitis, disciform keratitis, disciform keratouveitis, and necrotic stromal keratitis. Disciform keratouveitis and necrotic stromal keratitis are associated more commonly with elevated IOP than epithelial keratitis.
      • The elevated IOP may be caused by trabeculitis, inflammatory obstruction of the trabecular meshwork, and angle closure in severe keratouveitis. The management of elevated IOP initially is directed toward controlling the viral replication and inflammation.
    • Varicella zoster
      • Ocular involvement of cutaneous varicella zoster occurs in two thirds of patients when the ophthalmic division of the trigeminal nerve is involved. Dendritic keratitis, stromal keratitis, and exposure keratitis are common.
      • IOP elevation and glaucoma are believed to be caused by decreased outflow facility due to trabecular obstruction from inflammatory debris, trabeculitis, and damage to the trabecular meshwork by recurrent inflammation. Treatment with systemic acyclovir when the cutaneous lesions are still active appears to reduce the risk of elevated IOP.[1]
Previous
 
 
Contributor Information and Disclosures
Author

Leon Herndon Jr, MD  Associate Professor, Department of Ophthalmology, Duke University Medical Center

Leon Herndon Jr, MD is a member of the following medical societies: American Glaucoma Society

Disclosure: Alcon Honoraria Speaking and teaching; Allergan Honoraria Speaking and teaching; Ista Honoraria Speaking and teaching

Specialty Editor Board

Neil T Choplin, MD  Adjunct Clinical Professor, Department of Surgery, Section of Ophthalmology, Uniformed Services University of Health Sciences

Neil T Choplin, MD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, Association for Research in Vision and Ophthalmology, and California Medical Association

Disclosure: Nothing to disclose.

Simon K Law, MD, PharmD  Associate Professor of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology

Disclosure: Nothing to disclose.

Martin B Wax, MD  Clinical Professor, Department of Ophthalmology, University of Texas Southwestern Medical School; Vice President, Ophthalmology Research and Development, Head, Ophthalmology Discovery Research, Alcon Labs, Inc

Martin B Wax, MD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Society for Neuroscience

Disclosure: Nothing to disclose.

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Callanan DG, Jaffe GJ, Martin DF, Pearson PA, Comstock TL. Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol. Sep 2008;126(9):1191-201. [Medline].

  2. Bollinger K, Kim J, Lowder CY, Kaiser PK, Smith SD. Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis. Ophthalmology. Oct 2011;118(10):1927-31. [Medline].

  3. Hunter RS, Lobo AM. Dexamethasone intravitreal implant for the treatment of noninfectious uveitis. Clin Ophthalmol. 2011;5:1613-21. [Medline].

  4. Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA, et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. Oct 2011;118(10):1916-26. [Medline]. [Full Text].

  5. Malone PE, Herndon LW, Muir KW, Jaffe GJ. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma. Am J Ophthalmol. May 2010;149(5):800-6.e1. [Medline].

  6. Horsley MB, Chen TC. The use of prostaglandin analogs in the uveitic patient. Semin Ophthalmol. Jul-Sep 2011;26(4-5):285-9. [Medline].

  7. Markomichelakis NN, Kostakou A, Halkiadakis I, Chalkidou S, Papakonstantinou D, Georgopoulos G. Efficacy and safety of latanoprost in eyes with uveitic glaucoma. Graefes Arch Clin Exp Ophthalmol. Jun 2009;247(6):775-80. [Medline].

  8. Hoskins DH, Hetherington J, Shaffer RN. Surgical management of the inflammatory glaucomas. Perspect Ophthalmol. 1977;1:173-81.

  9. Hill RA, Nguyen QH, Baerveldt G, et al. Trabeculectomy and Molteno implantation for glaucomas associated with uveitis. Ophthalmology. Jun 1993;100(6):903-8. [Medline].

  10. Wright MM, McGehee RF, Pederson JE. Intraoperative mitomycin-C for glaucoma associated with ocular inflammation. Ophthalmic Surg Lasers. May 1997;28(5):370-6. [Medline].

  11. Hill RA, Heuer DK, Baerveldt G, et al. Molteno implantation for glaucoma in young patients. Ophthalmology. Jul 1991;98(7):1042-6. [Medline].

  12. Ceballos EM, Parrish RK, Schiffman JC. Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology. Dec 2002;109(12):2256-60. [Medline].

  13. Ozdal PC, Vianna RN, Deschenes J. Ahmed valve implantation in glaucoma secondary to chronic uveitis. Eye. Feb 2006;20(2):178-83. [Medline].

  14. Rachmiel R, Trope GE, Buys YM, Flanagan JG, Chipman ML. Ahmed glaucoma valve implantation in uveitic glaucoma versus open-angle glaucoma patients. Can J Ophthalmol. Aug 2008;43(4):462-7. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.